What the test screens for
Core panel (Standard)
Trisomy 21 (Down syndrome), Trisomy 18 (Edwards), Trisomy 13 (Patau).
Extended (on request)
Sex-chromosome aneuploidies (SCAs): Turner (45,X), Klinefelter (47,XXY), Triple-X (47,XXX), XYY — offered with clinician guidance.
Optional add-on (post-counselling)
Selected microdeletions (e.g., 22q11.2 deletion) — note that routine microdeletion screening is not recommended in unselected populations due to low prevalence and higher false-positive rates; available only if clinically indicated. Prescription is mandatory.
			Who should consider NIPT?
Leading societies recognise cfDNA/NIPT as a screening option for all pregnant patients with shared decision-making. Particularly useful with increased maternal age, a prior positive screen, ultrasound soft markers, or relevant history.
How it works (simple 4-step flow)
Schedule your slot (centre visit or home collection).
Sample: one blood draw into cfDNA stabilisation tubes — no fasting needed.
Analysis: NGS-based cfDNA analysis with quality checks (incl. fetal fraction).
Report & counselling: digital report in ~5–7 business days; results discussed with a counsellor/obstetrician, and diagnostic testing arranged when appropriate.
What’s included

Pre-test eligibility check & PCPNDT-compliant consent

Blood collection
In-clinic or home

Digital report + clinician sign-off

Post-test review with clear next-step pathway (diagnostic testing referral if high-risk)
Preparation & special situations
- Gestation: from 10 weeks.
 - Bring: photo ID, obstetric file, prior screening/ultrasound reports.
 - Twins, IVF/donor egg, high BMI, vanishing twin, recent transfusion/transplant may affect test performance; your clinician will advise and may suggest redraw or diagnostic testing if low foetal fraction or discordant findings occur.
 
Limitations & safety (read before booking)
- NIPT is not diagnostic; positive/high-risk results must be confirmed with CVS/Amniocentesis.
 - It does not detect all genetic problems (e.g., most single-gene disorders, many structural anomalies).
 - Microdeletions: not recommended for routine screening in the general population; offer selectively after counselling.
 
Legal & ethical compliance (India)
We adhere strictly to the PC-PNDT Act. Sex determination/disclosure is illegal, and we do not test for or disclose foetal sex. Where SCA analysis is clinically indicated, reporting follows legal and professional guidance.
Frequently Asked Questions
Is NIPT safe for my baby?
Yes. It’s a maternal blood test—no risk to the foetus.
When can I take the test?
How accurate is NIPT?
Can I add microdeletions?
Will the report reveal my baby’s sex?
What if my report says “no-call/low foetal fraction”?
Sample Collection Options
1. Any of the following RxDx Clinic branches
- RxDx Clinics, Whitefield
 - RxDx Clinics NM Medical, Domlur
 - RxDx Clinics, Jakkur
 - RxDx SAMANVAY Clinics, Malleswaram
 - RxDx Clinics, APR Villas, Bellandur (residents only)
 - RxDx Clinics, Kadugodi
 - RxDx Clinics, Siddapura
 - RxDx Clinics, RR Nagar
 - RxDx Clinics, Electronic City (coming soon)
 - RxDx Clinics, Budigere (coming soon)
 






